Compare MLAB & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLAB | SIBN |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 719.9M | 778.8M |
| IPO Year | 1995 | 2018 |
| Metric | MLAB | SIBN |
|---|---|---|
| Price | $127.56 | $19.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $117.50 | $25.22 |
| AVG Volume (30 Days) | 89.9K | ★ 536.4K |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | ★ 0.50% | N/A |
| EPS Growth | ★ 436.11 | 41.33 |
| EPS | ★ 0.49 | N/A |
| Revenue | N/A | ★ $67,301,000.00 |
| Revenue This Year | $2.14 | $15.53 |
| Revenue Next Year | $6.45 | $15.64 |
| P/E Ratio | $261.37 | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $69.43 | $11.48 |
| 52 Week High | $144.35 | $21.89 |
| Indicator | MLAB | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 49.61 | 61.72 |
| Support Level | $89.77 | $16.34 |
| Resistance Level | $132.70 | $20.30 |
| Average True Range (ATR) | 5.03 | 0.68 |
| MACD | -1.26 | 0.14 |
| Stochastic Oscillator | 15.89 | 92.21 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.